Teriflunomide Tablet, Film Coated
Product Images NDC 70710-1115

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Teriflunomide (NDC 70710-1115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Teriflunomide Tablets (3d0a3975 6caf 45a7 90a3 19f0725d4697 01)

Chemical structure of teriflunomide, showing its molecular arrangement including a trifluoromethyl-substituted aromatic ring, amide group, and nitrile functional group.*

FDA Label Image

Teriflunomide Tablets (3d0a3975 6caf 45a7 90a3 19f0725d4697 02)

A line graph showing disability progression sustained for 12 weeks (%) over time (weeks) comparing placebo and Teriflunomide oral tablets at 7 mg and 14 mg doses. The graph includes three curves representing placebo, 7 mg, and 14 mg Teriflunomide groups, with disability progression percentages noted near the end of the study period. A table below the graph lists the number of patients at risk at various time points for each group. A note indicates statistical significance for the 14 mg Teriflunomide group versus placebo (p<0.05).*

FDA Label Image

Teriflunomide Tablets (3d0a3975 6caf 45a7 90a3 19f0725d4697 03)

A line graph comparing disability progression sustained for 12 weeks over time (weeks) among Placebo, 7 mg Teriflunomide, and 14 mg Teriflunomide treatment groups. The graph shows percentages on the vertical axis and includes a table of the number at risk for each group over time. The 14 mg Teriflunomide group shows a statistically significant difference compared to placebo (p<0.05).*

FDA Label Image

Teriflunomide Tablets (3d0a3975 6caf 45a7 90a3 19f0725d4697 04)

Teriflunomide Tablets 7 mg film-coated oral tablets label by Zydus Pharmaceuticals USA Inc. The label indicates a package of 30 tablets with prescription use only, containing 7 mg of Teriflunomide each. Instructions note dispensing the Medication Guide separately. Storage and warning information is also visible.*

FDA Label Image

Teriflunomide Tablets (3d0a3975 6caf 45a7 90a3 19f0725d4697 05)

Label for Teriflunomide Tablets 14 mg film-coated oral tablets by Zydus Pharmaceuticals USA Inc. The package contains 30 tablets, prescription only. Label includes dosing directions, storage instructions, child-resistant packaging note, and manufacturer information for Zydus Lifesciences Ltd., India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.